We reasoned that our large multidimensional data with demographic, cognitive and APOE genotype data, as well as plasma protein levels provided an opportunity to develop a machine learning algorithm to classify MCI individuals into MCI-stable versus MCI-progressors and, thus, predict progression from MCI to dementia. Here, APOE is linked to dementia.